LabGenius Therapeutics
AI-driven drug discovery platform for rapid development of novel therapeutics.
About
Technology stack
detected 2026-06-13No comments yet. Be the first to share your take.
What does LabGenius Therapeutics do?
LabGenius Therapeutics is an AI-driven drug discovery company that leverages its proprietary platform to accelerate the development of novel therapeutics. Their approach combines advanced machine learning with high-throughput experimentation to identify and optimize drug candidates more efficiently than traditional methods.
How much funding has LabGenius Therapeutics raised?
LabGenius Therapeutics has raised a total of $3M in funding. The most recent round on record is Seed.
Where is LabGenius Therapeutics headquartered?
LabGenius Therapeutics is headquartered in London, United Kingdom.
When was LabGenius Therapeutics founded?
LabGenius Therapeutics was founded in 2019.
What industry does LabGenius Therapeutics operate in?
LabGenius Therapeutics operates in Biotech, Drug Discovery, AI-Driven Protein Design, HealthTech, Foundation Model, Generative AI.